InvestorsObserver is giving Johnson & Johnson (JNJ) an Analyst Ranking Rank of 61, that means JNJ is ranked increased by analysts than 61% of stocks. The common projection by analysts for JNJ is $168.25 over the subsequent 12 months and analyst’s classify the stock as a Sturdy Purchase
Why are Analyst Rankings Necessary?
An organization’s monetary statements are a big issue weighted by consultants when analyzing an organization’s well being. Past simply the numbers, analysts comply with particular industries intently and are in a position to achieve an in depth understanding of how a storm in a single a part of the world can shutdown provide chains resulting in a change in consumption throughout the globe. This information permits buyers to answer potential modifications out there earlier than they’re revealed in a quarterly annoucement.
InvestorsObserver averages the rankings throughout all these analysts and percentile ranks these averages. This lets you evaluate stocks in better element than the same old five-tiered system used amongst the vast majority of buyers.
What’s Taking place With Johnson & Johnson Stock In the present day?
Johnson & Johnson (JNJ) stock is buying and selling at $152.71 as of 3:24 PM on Thursday, Dec 10, a decline of -$0.29, or -0.19% from the earlier closing price of $153.00. Quantity right this moment is much less lively than traditional. Thus far 3,960,527 shares have traded in comparison with common quantity of seven,720,020 shares. The stock has traded between $151.68 and $152.98 to date right this moment.
Click on Right here to get the total report on Johnson & Johnson (JNJ) Stock.